Do 5 alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?

Abstract not available.

View Source

Information

Citation

Welk B, Reid J, Ordon M, Campbell J, Dixon S. Can Urol Assoc J. 2021; 15(6):214-6. Epub 2021 Jan 29.

View Source

Contributing ICES Scientists

Research Programs

Kidney, Dialysis & Transplantation

Associated Sites

ICES Western

Discover More

Journal Article

27/08/2024

5-alpha reductase inhibitors and prostate cancer mortality

Hamilton RJ, Chavarriaga J, Khurram N, Lau C, Luo J, Liu N, Komisarenko M, Kulkarni G, Wallis C, Juurlink DN, Fleshner N, Finelli A. JAMA Netw Open. 2024; 7(8):e2430223.

Journal Article

27/08/2024

Pregnancy complications and new-onset maternal autoimmune disease

Scime NV, Grandi SM, Ray JG, Dennis CL, De Vera MA, Banack HR, Vigod SN, Boblitz A, Brown HK. Int J Epidemiol. 2024; 53(5):dyae115.

Journal Article

26/08/2024

Disparities in surgery rates during the COVID-19 pandemic: retrospective study

Sankar A, Stukel TA, Baxter NN, Wijeysundera DN, Hwang SW, Wilton AS, Chan TCY, Sarhangian V, Simpson AN, de Mestral C, Pincus D, Campbell RJ, Urbach DR, Irish J, Gomez D. BJS Open. 2024; 8(4):zrae088.

See All